Prevalence of positive antinuclear antibodies in healthy children

Siriwan Wananukul1, Wanlapa Voramethkul, Yadah Kaewopas

  • 1Division of Pediatric Dermatology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand. wananusw@hotmail.com

Insights

The prevalence of antinuclear antibodies (ANA) in healthy children is 15% at a 1:40 dilution or higher. This finding is crucial for accurately diagnosing connective tissue diseases in pediatric patients.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Clinical Diagnostics

Background:

  • Antinuclear antibodies (ANA) are key biomarkers for diagnosing pediatric connective tissue diseases.
  • Understanding the prevalence of ANA in healthy children is essential for accurate diagnostic interpretation.

Purpose of the Study:

  • To determine the prevalence of antinuclear antibodies (ANA) in a healthy pediatric population.
  • To establish baseline ANA levels for comparison with disease states.

Main Methods:

  • Indirect immunofluorescence assay using HEp-2 cells was performed on 207 serum samples from healthy children.
  • Serum samples were tested for ANA at dilutions of 1:40 and higher.
  • ANA results were compared with those from 52 pediatric Systemic Lupus Erythematosus (SLE) patients.

Main Results:

  • Antinuclear antibodies were detected in 15% of healthy children at a dilution of 1:40 or higher.
  • Specific prevalence rates in healthy children were 9% at 1:40, 3% at 1:80, and 3% at 1:160.
  • ANA positivity in pediatric SLE patients was 91%, with varying titers.

Conclusions:

  • The prevalence of ANA in healthy children, using HEp-2 cells and a 1:40 dilution cutoff, is 15%.
  • The test demonstrated high sensitivity (91%) and negative predictive value (97%) for ANA detection.
  • This study provides critical data for interpreting ANA results in pediatric autoimmune disease evaluations.